Identifying cancer mutations as therapeutic targets

J Natl Cancer Inst. 2014 Aug 13;106(8):dju276. doi: 10.1093/jnci/dju276. Print 2014 Aug.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Biomarkers, Tumor / genetics*
  • Human Genome Project
  • Humans
  • Molecular Targeted Therapy*
  • Mutation* / drug effects
  • National Cancer Institute (U.S.)
  • Neoplasm Proteins / drug effects
  • Neoplasm Proteins / genetics*
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Predictive Value of Tests
  • Sequence Analysis, DNA*
  • United States

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Neoplasm Proteins